Group 12: Teodora Simic, Jenny Shin, Divya Singh, Victor Shen [dAKT1oVruN4]
References 1. Bondareva, A., Downey, C., Ayres, F., Liu, W., Boyd, S., Hallgrimsson, B. and Jirik, F. (2009). The Lysyl Oxidase Inhibitor, β-Aminopropionitrile, Diminishes the Metastatic Colonization Potential of Circulating Breast Cancer Cells. PLoS ONE, 4(5), p.e5620. 2. Chi, J., Wang, Z., Nuyten, D., Rodriguez, E., Schaner, M., Salim, A., Wang, Y., Kristensen, G., Helland, Å., Børresen-Dale, A., Giaccia, A., Longaker, M., Hastie, T., Yang, G., van de Vijver, M. and Brown, P. (2006). Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers. PLoS Medicine, 3(3), p.e47. 3. Chvapil, M. (2005). Inhibition of breast adenocarcinoma growth by intratumoral injection of lipophilic long-acting lathyrogens. Anti-Cancer Drugs, 16(2), pp.201-210. 4. Csiszar, K. (2001). Lysyl oxidases: A novel multifunctional amine oxidase family. Progress in Nucleic Acid Research and Molecular Biology, pp.1-32. 5. Erler, J., Bennewith, K., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q., Chi, J., Jeffrey, S. and Giaccia, A. (2006). Lysyl oxidase is essential for hypoxia- induced metastasis. Nature, 440(7088), pp.1222-1226. 6. Gartland, A., Erler, J. and Cox, T. (2016). The role of lysyl oxidase, the extracellular matrix and the pre-metastatic niche in bone metastasis. Journal of Bone Oncology, 5(3), pp.100-103. 7. Gomis, R. and Gawrzak, S. (2017). Tumor cell dormancy. Molecular Oncology, 11(1), pp.62-78. 8. Heino, J. (1993). Integrin-type Extracellular Matrix Receptors in Cancer and Inflammation. Annals of Medicine, 25(4), pp.335-342. 9. Kimbro, K. (2006). Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocrine Related Cancer, 13(3), pp.739-749. 10. Masoud, G. and Li, W. (2015). HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharmaceutica Sinica B, 5(5), pp.378-389. 11. Nilsson, M., Hägglöf, C., Hammarsten, P., Thysell, E., Stattin, P., Egevad, L., Granfors, T., Jernberg, E., Wikstrom, P., Halin Bergström, S. and Bergh, A. (2015). High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting. PLoS ONE, 10(10), p.e0140985. 12. Peacock, E. and Madden, J. (1978). Administration of beta-aminopropionitrile to human beings with urethral strictures: A preliminary report. The American Journal of Surgery, 136(5), pp.600-605. 13. Rodríguez, C., Rodríguez-Sinovasm, A. and Martínez-González, J. (2008). Lysyl oxidase as a potential therapeutic target. Drug News & Perspectives, 21(4), p.218. 14. Rucker, Robert & Kosonen, T & Clegg, Michael & Mitchell, Alyson & R Rucker, B & Uriu-Adams, Jan & Keen, Carl. (1998). Copper, lysyl oxidase, and extracellular matrix protein cross-linking. The American journal of clinical nutrition, 67, pp.996-1002.